A new multicenter clinical trial published in Diabetes, Obesity & Metabolism suggests that intensifying treatment with a ...
Study 1 randomized 20 subjects, and all subjects received at least one dose of the study treatment. Most subjects were male (70%), white (65%), and not Hispanic or Latino (85%). The mean age was 32.2 ...
Metformin at lower doses appears to be safe and effective for type 2 diabetes patients suffering from stages 3, and 4 chronic kidney disease (CKD). Scientists evaluated the use of metformin in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results